SARS coronavirus and innate immunity
暂无分享,去创建一个
[1] Jing Li,et al. Analysis of Serum Cytokines in Patients with Severe Acute Respiratory Syndrome , 2004, Infection and Immunity.
[2] B. Williams,et al. Blockade of Interferon Induction and Action by the E3L Double-Stranded RNA Binding Proteins of Vaccinia Virus , 2002, Journal of Virology.
[3] G. Sen,et al. Viruses and interferons. , 2001, Annual review of microbiology.
[4] Renji Reghunathan,et al. Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome , 2005, BMC Immunology.
[5] S. Perlman,et al. Mouse Hepatitis Virus Does Not Induce Beta Interferon Synthesis and Does Not Inhibit Its Induction by Double-Stranded RNA , 2006, Journal of Virology.
[6] W. Spaan,et al. Group 2 coronaviruses prevent immediate early interferon induction by protection of viral RNA from host cell recognition , 2007, Virology.
[7] M. Katze,et al. Global Suppression of the Host Antiviral Response by Ebola- and Marburgviruses: Increased Antagonism of the Type I Interferon Response Is Associated with Enhanced Virulence , 2006, Journal of Virology.
[8] M. Diamond,et al. Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus. , 2003, Viral immunology.
[9] J. Peiris,et al. Academic Editor: Sherif Zaki, Centers for Disease Control, United States of America , 2005 .
[10] S. Akira,et al. Recognition of pathogen-associated molecular patterns by TLR family. , 2003, Immunology letters.
[11] J. Hiscott,et al. Recruitment of an interferon molecular signaling complex to the mitochondrial membrane: disruption by hepatitis C virus NS3-4A protease. , 2006, Biochemical pharmacology.
[12] A. Pichlmair,et al. RIG-I-Mediated Antiviral Responses to Single-Stranded RNA Bearing 5'-Phosphates , 2006, Science.
[13] Persephone Borrow,et al. Viral infection switches non-plasmacytoid dendritic cells into high interferon producers , 2003, Nature.
[14] S. Schleich,et al. Localization of Mouse Hepatitis Virus Nonstructural Proteins and RNA Synthesis Indicates a Role for Late Endosomes in Viral Replication , 1999, Journal of Virology.
[15] S. Diamond,et al. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[16] S. Weiss,et al. Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus , 2005, Microbiology and Molecular Biology Reviews.
[17] C. Agrati,et al. Coordinate induction of IFN-α and -γ by SARS-CoV also in the absence of virus replication , 2005, Virology.
[18] R. Baric,et al. Coronavirus Genome Structure and Replication , 2005, Current topics in microbiology and immunology.
[19] N. Kadowaki,et al. The nature of the principal type 1 interferon-producing cells in human blood. , 1999, Science.
[20] T. Ouchi,et al. Measles Virus V Protein Inhibits p53 Family Member p73 , 2006, Journal of Virology.
[21] Andreas Pichlmair,et al. Inhibition of Beta Interferon Induction by Severe Acute Respiratory Syndrome Coronavirus Suggests a Two-Step Model for Activation of Interferon Regulatory Factor 3 , 2005, Journal of Virology.
[22] P. Österlund,et al. Severe Acute Respiratory Syndrome Coronavirus Fails To Activate Cytokine-Mediated Innate Immune Responses in Cultured Human Monocyte-Derived Dendritic Cells , 2005, Journal of Virology.
[23] F. Weber,et al. Interaction of severe acute respiratory syndrome-associated coronavirus with dendritic cells. , 2006, The Journal of general virology.
[24] C. Hsiao,et al. Modeling the Early Events of Severe Acute Respiratory Syndrome Coronavirus Infection In Vitro , 2006, Journal of Virology.
[25] S. Nichol,et al. A C-terminal basic amino acid motif of Zaire ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza A virus. , 2004, Virology.
[26] H. Doerr,et al. Infection of cultured intestinal epithelial cells with severe acute respiratory syndrome coronavirus , 2004, Cellular and Molecular Life Sciences CMLS.
[27] Andrew Pekosz,et al. The ORF7b Protein of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Is Expressed in Virus-Infected Cells and Incorporated into SARS-CoV Particles , 2006, Journal of Virology.
[28] A. Alcamí,et al. Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species soecificity , 1995, Cell.
[29] T. Graf,et al. Determinants of lymphoid-myeloid lineage diversification. , 2006, Annual review of immunology.
[30] Christine A. Biron,et al. Type 1 Interferons and the Virus-Host Relationship: A Lesson in Détente , 2006, Science.
[31] C. Peters,et al. Severe Acute Respiratory Syndrome Coronavirus Accessory Protein 6 Is a Virion-Associated Protein and Is Released from 6 Protein-Expressing Cells , 2007, Journal of Virology.
[32] H. Laude,et al. Induction of alpha interferon by transmissible gastroenteritis coronavirus: role of transmembrane glycoprotein E1 , 1988, Journal of virology.
[33] Tzei-Yi Lin,et al. Detection of Severe Acute Respiratory Syndrome–Associated Coronavirus in Pneumocytes of the Lung , 2004, American journal of clinical pathology.
[34] Erica Ollmann Saphire,et al. Ebola Virus VP35 Protein Binds Double-Stranded RNA and Inhibits Alpha/Beta Interferon Production Induced by RIG-I Signaling , 2006, Journal of Virology.
[35] Christian Drosten,et al. Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome , 2003, Science.
[36] S. Makino,et al. Severe Acute Respiratory Syndrome Coronavirus 7a Accessory Protein Is a Viral Structural Protein , 2006, Journal of Virology.
[37] A. Takaoka,et al. Interferon signalling network in innate defence , 2006, Cellular microbiology.
[38] V. Volchkov,et al. The Ebola virus VP35 protein functions as a type I IFN antagonist. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[39] E. Saphire,et al. Ebola Virus VP 35 Protein Binds Double-Stranded RNA and Inhibits Alpha / Beta Interferon Production Induced by RIGI Signaling , 2006 .
[40] Obi L. Griffith,et al. The Genome Sequence of the SARS-Associated Coronavirus , 2003, Science.
[41] Deborah Chavez,et al. Antiviral Effect and Virus-Host Interactions in Response to Alpha Interferon, Gamma Interferon, Poly(I)-Poly(C), Tumor Necrosis Factor Alpha, and Ribavirin in Hepatitis C Virus Subgenomic Replicons , 2003, Journal of Virology.
[42] B. Hogue,et al. Mouse Hepatitis Coronavirus A59 Nucleocapsid Protein Is a Type I Interferon Antagonist , 2006, Journal of Virology.
[43] R. Baric,et al. Single-Amino-Acid Substitutions in Open Reading Frame (ORF) 1b-nsp14 and ORF 2a Proteins of the Coronavirus Mouse Hepatitis Virus Are Attenuating in Mice , 2005, Journal of Virology.
[44] H. Tsutsumi,et al. Cytokine regulation in SARS coronavirus infection compared to other respiratory virus infections† , 2006, Journal of medical virology.
[45] J. A. Comer,et al. Ultrastructural Characterization of SARS Coronavirus , 2004, Emerging infectious diseases.
[46] J. Onderwater,et al. Ultrastructure and Origin of Membrane Vesicles Associated with the Severe Acute Respiratory Syndrome Coronavirus Replication Complex , 2006, Journal of Virology.
[47] Qiang Sun,et al. Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKε Molecular Complex from the Mitochondrial Outer Membrane by Hepatitis C Virus NS3-4A Proteolytic Cleavage , 2006, Journal of Virology.
[48] T. Hovi,et al. Induction of interferon in human leukocyte cultures by natural pathogenic respiratory viruses. , 1993, Journal of interferon research.
[49] G. Stark,et al. How cells respond to interferons. , 1998, Annual review of biochemistry.
[50] Xiaotao Lu,et al. Effects of Mutagenesis of Murine Hepatitis Virus NSP1 and NSP14 on Replication in Culture , 2006, Advances in experimental medicine and biology.
[51] R. Lamb,et al. The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2. , 2001, Virology.
[52] J. Hiscott,et al. MasterCARD: a priceless link to innate immunity. , 2006, Trends in molecular medicine.
[53] M. Gunn,et al. Cd11c+B220+Gr-1+ Cells in Mouse Lymph Nodes and Spleen Display Characteristics of Plasmacytoid Dendritic Cells , 2001, The Journal of experimental medicine.
[54] P. Palese,et al. Severe Acute Respiratory Syndrome Coronavirus Open Reading Frame (ORF) 3b, ORF 6, and Nucleocapsid Proteins Function as Interferon Antagonists , 2006, Journal of Virology.
[55] Nicole M. Bouvier,et al. Newcastle Disease Virus (NDV)-Based Assay Demonstrates Interferon-Antagonist Activity for the NDV V Protein and the Nipah Virus V, W, and C Proteins , 2003, Journal of Virology.
[56] S. Goodbourn,et al. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[57] Kwok-Hung Chan,et al. Comparative Host Gene Transcription by Microarray Analysis Early after Infection of the Huh7 Cell Line by Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus 229E , 2005, Journal of Virology.
[58] M. Yilla,et al. SARS-coronavirus replication in human peripheral monocytes/macrophages , 2004, Virus Research.
[59] D. Jarrossay,et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon , 1999, Nature Medicine.
[60] F. Taguchi,et al. Difference in sensitivity to interferon among mouse hepatitis viruses with high and low virulence for mice , 1985, Virology.
[61] K. Bienz,et al. RNA Replication of Mouse Hepatitis Virus Takes Place at Double-Membrane Vesicles , 2002, Journal of Virology.
[62] Zhengfan Jiang,et al. Antagonism between MyD88‐ and TRIF‐dependent signals in B7RP‐1 up‐regulation , 2005, European journal of immunology.
[63] Zhijian J. Chen,et al. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[64] Lucy A. Perrone,et al. Severe Acute Respiratory Syndrome and the Innate Immune Responses: Modulation of Effector Cell Function without Productive Infection1 , 2005, The Journal of Immunology.
[65] Michael G. Katze,et al. Viruses and interferon: a fight for supremacy , 2002, Nature Reviews Immunology.
[66] G. Tse,et al. Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in‐situ hybridization study of fatal cases , 2004, The Journal of pathology.
[67] Tomoki Ito,et al. Plasmacytoid dendritic cell precursors/type I interferon-producing cells sense viral infection by Toll-like receptor (TLR) 7 and TLR9 , 2004, Springer Seminars in Immunopathology.
[68] M. Katze,et al. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. , 1997, Virology.
[69] C. Horvath,et al. Nipah Virus V Protein Evades Alpha and Gamma Interferons by Preventing STAT1 and STAT2 Activation and Nuclear Accumulation , 2002, Journal of Virology.
[70] Zheng-hong Yuan,et al. Gene expression profiles in peripheral blood mononuclear cells of SARS patients. , 2005, World journal of gastroenterology.
[71] Stanley M Lemon,et al. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[72] S. Akira,et al. Control of coronavirus infection through plasmacytoid dendritic-cell–derived type I interferon , 2007, Blood.
[73] G. Trinchieri,et al. Plasmacytoid dendritic cells in immunity , 2004, Nature Immunology.
[74] Ralf Bartenschlager,et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus , 2005, Nature.
[75] Y. Lau,et al. Chemokine up-regulation in SARS-coronavirus–infected, monocyte-derived human dendritic cells , 2005, Blood.
[76] J. Lindenmann,et al. Virus interference. I. The interferon , 1957, Proceedings of the Royal Society of London. Series B - Biological Sciences.
[77] W. Hong,et al. The severe acute respiratory syndrome coronavirus 3a is a novel structural protein , 2005, Biochemical and Biophysical Research Communications.
[78] M. Denison,et al. Characterization of the Expression, Intracellular Localization, and Replication Complex Association of the Putative Mouse Hepatitis Virus RNA-Dependent RNA Polymerase , 2003, Journal of Virology.
[79] Gunther Hartmann,et al. 5'-Triphosphate RNA Is the Ligand for RIG-I , 2006, Science.
[80] Jun Xu,et al. Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. , 2005, American journal of respiratory and critical care medicine.